Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.
Lancet (London, England) · 2025 · 275 citations · David Madoff
Video versus Direct Laryngoscopy for Tracheal Intubation of Critically Ill Adults.
The New England journal of medicine · 2023 · 267 citations · Shekhar Ghamande
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 571 citations · David Madoff
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 447 citations · Barbara Burtness
Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2022 · 418 citations · Barbara Burtness
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 587 citations · Daniela Matei
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.
The New England journal of medicine · 2022 · 459 citations · Matthew Sims
Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.
BMJ (Clinical research ed.) · 2022 · 544 citations · Shekhar Ghamande